7 May 2020
The news that experts expect that the first vaccine against COVID-19 could be available in Q3 2020, prompted the interviewer to find out why these vaccine studies are carried out in Rhesus monkeys. Otto Boerman explained why the vast majority of animal studies are carried out in mice and rats, while other experiments are carried out in other species (e.g. guinea pigs, rabbits, sheep a.o.) and that a minority is carried out in nonhuman primates.
Thursday 30 April Otto Boerman was interviewed on NPO radio 1 on studies in laboratory animals for the development of a vaccine against COVID-19. Otto Boerman, director of the Animal Research Facility (CDL) was interviewed during the radio show ‘Met het Oog op Morgen’ by Marcia Luyten.
The news that experts expect that the first vaccine against COVID-19 could be available in Q3 2020, prompted the interviewer to find out why these vaccine studies are carried out in Rhesus monkeys. Otto Boerman explained why the vast majority of animal studies are carried out in mice and rats, while other experiments are carried out in other species (e.g. guinea pigs, rabbits, sheep a.o.) and that a minority is carried out in nonhuman primates.